Rogier Baak

Erasmus MC Cancer Institute

Papers

1

Total Citations

2

H-Index

1

About

Rogier Baak is a radiation oncology researcher whose work focuses on improving the precision and safety of stereotactic body radiation therapy (SBRT) for challenging abdominal tumors. His primary research areas include image-guided radiotherapy, respiratory motion management, and dose verification in high-precision treatments. Baak’s most notable contribution comes from his work on the prospective phase I STRONG trial, where he investigated inter- and intrafraction dose variations in robotic SBRT for perihilar cholangiocarcinoma. By using fiducial-marker-based robotic respiratory tumor tracking and acquiring in-room diagnostic-quality repeat CTs before and after dose delivery across 15 daily fractions of 4 Gy, he demonstrated how real-time adaptation can mitigate anatomical changes. This work, published in 2023, has already garnered attention with 2 citations, highlighting its relevance to the growing field of adaptive radiotherapy. Baak’s research provides critical insights into dose delivery accuracy, helping to establish safer treatment protocols for patients with complex upper abdominal malignancies. His meticulous approach to quantifying dose variations positions him as a rising expert in motion-managed SBRT.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Erasmus MC Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago